We showed the tendency of shorter TTFT in groups of CLL patients with high TLR9 expression in comparison to low TLR9 expression in BBMC (12 vs. 45, p = 0.0655). The gene discussed is TLR9; the disease is B-cell chronic lymphocytic leukemia.